Lisanti Capital Growth LLC Takes $3.16 Million Position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)

Lisanti Capital Growth LLC purchased a new stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 62,415 shares of the company’s stock, valued at approximately $3,158,000. Other institutional investors and hedge funds […]

Related Keywords

United States ,William Blair ,Joseph Baroldi ,Piper Sandler ,Ionis Pharmaceuticals ,Quarter For Ionis Pharmaceuticals ,C Worldwide Group Holding ,Wolfe Research ,Securities Exchange Commission ,Ionis Pharmaceuticals Price Performance ,Associates Corp ,Victory Capital Management Inc ,T Bank Corp ,Nasdaq ,News Ratings For Ionis Pharmaceuticals Daily ,Ionis Pharmaceuticals Inc ,Lisanti Capital Growth ,Jpmorgan Chase Co ,Ionis Pharmaceuticals Profile ,Free Report ,Capital Management ,Get Free Report ,Visit Holdingschannel ,Ionis Pharmaceuticals Daily ,Nasdaq Ions ,Lions ,Medical ,46433010 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,